Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer

被引：0
|
作者：
Magagnoli, M [1 ]
Masci, G [1 ]
Castagna, L [1 ]
Rimassa, L [1 ]
Bramanti, S [1 ]
Santoro, A [1 ]
机构：
[1] Ist Clin Humanitas, Dept Med Oncol & Hematol, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 12期
关键词：
D O I：
10.1038/sj.bmt.1704527
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1261 / 1262
页数：2
相关论文
共 50 条
  • [1] Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer
    M Magagnoli
    G Masci
    L Castagna
    L Rimassa
    S Bramanti
    A Santoro
    [J]. Bone Marrow Transplantation, 2004, 33 : 1261 - 1262
  • [2] INTERMEDIATE-DOSE MELPHALAN FOR REFRACTORY MYELOMA - RESPONSE
    BARLOGIE, B
    ALEXANIAN, R
    SMALLWOOD, L
    CHESON, B
    DIXON, D
    DICKE, K
    CABANILLAS, F
    [J]. BLOOD, 1989, 74 (03) : 1177 - 1177
  • [3] Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma
    Palumbo, Antonio
    Avonto, Ilaria
    Bruno, Benedetto
    Falcone, Antonietta
    Scalzulli, Polito Rosario
    Ambrosini, Maria Teresa
    Bringhen, Sara
    Gay, Francesca
    Rus, Cecilia
    Cavallo, Federica
    Falco, Patrizia
    Massaia, Massimo
    Musto, Pellegrino
    Boccadoro, Mario
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06): : 475 - 477
  • [4] High dose melphalan therapy with stem-cell support in primary systemic amyloidosis
    Rives, S
    Bladé, J
    Martínez, C
    Marín, P
    Carreras, E
    Montserrat, E
    [J]. MEDICINA CLINICA, 2000, 115 (06): : 216 - 220
  • [5] Phase II study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer
    Wilailak, S
    Tresukosol, D
    Linasmita, V
    Termrungruanglert, W
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2000, 21 (06) : 610 - 612
  • [6] A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer
    Bryan Oronsky
    Carolyn M. Ray
    Alexander I. Spira
    Jane B. Trepel
    Corey A. Carter
    Hope M. Cottrill
    [J]. Medical Oncology, 2017, 34
  • [7] An evaluation of intermediate-dose ketoconazole in hormone refractory prostate cancer
    Wilkinson, S
    Chodak, G
    [J]. EUROPEAN UROLOGY, 2004, 45 (05) : 581 - 585
  • [8] High-dose melphalan with blood stem-cell support for AL amyloidosis.
    Comenzo, RL
    Vosburgh, E
    Sarnacki, DL
    Falk, R
    Simms, R
    Wright, DG
    Skinner, M
    [J]. BLOOD, 1995, 86 (10) : 813 - 813
  • [9] Phase II study of high-dose megestrol acetate in platinum-refractory epithelial ovarian cancer
    Wilailak, S
    Linasmita, V
    Srisupundit, S
    [J]. ANTI-CANCER DRUGS, 2001, 12 (09) : 719 - 724
  • [10] A study of pegylated liposomal doxorubicin in platinum-refractory epithelial ovarian cancer
    Wilailak, S
    Linasmita, V
    [J]. ONCOLOGY, 2004, 67 (3-4) : 183 - 186
12345